LETTER
One-Pot Preparation of Imidazolin-5-ones
317
The experimental observations suggest a ‘Type 1’ path-
way for the decomposition of ethyl a-azido(phe-
nyl)acetate18 that can be characterized by the initial
release of the molecular nitrogen and subsequent isomer-
ization of the nitrene to imine by 1,2-H shift.19 The mech-
anism for the conversion of a-imino esters into the
imidazolin-5-one heterocyclic system consists of two in-
dependent steps, nucleophilic attack and addition of the
imine group to the C=N double bond followed by conden-
sation reaction.20
Acknowledgment
This work was partially supported by the Polish Ministry of Science
and Higher Education (Grant No. N204 310037) and the Slovak Na-
tional Research and Development Program No. 2003SP200280203.
References and Notes
(1) Pandya, K. C.; Kurien, P. N.; Surange, V. R. J. Indian Chem.
Soc. 1934, 11, 823.
(2) Wright, W. B.; Brabander, H. J.; Hardy, R. A.; Osterberg,
A. C. J. Med. Chem. 1966, 9, 852.
Our research shows that formation of the nitrene can be
realized in the absence of any base by simple thermal de-
composition of a-azidoarylacetates in dipolar aprotic sol-
vents such as DMF or DMSO. We note that simple
aliphatic a-azido esters are more stable than a-azidoaryl-
acetates and do not undergo any thermal transformation
into nitrene derivatives below 120 °C, so they do not give
any aliphatic a-imino esters. We presume that there is a
correlation between the thermal stability of a-azido esters
and their a-CH acidity. Indeed, diethyl a-bromomalonate,
ethyl a-bromonitroacetate and ethyl a-bromocyanoace-
tate reacted quickly with sodium azide in DMF with ac-
companying nitrogen evolution even at room temperature.
GC of the reaction mixtures showed the absence of a-bro-
mo esters but spectroscopic analysis gave no evidence for
formation of imidazolin-5-ones. NMR investigation of
crude products indicated the formation of a-imino esters
as main products. However, separation of pure a-imino
esters was not possible owing to their hydrolytic instabil-
ity. When we tried to isolate diethyl iminomalonate21 after
reaction of diethyl a-bromomalonate with sodium azide,
NMR analysis of the crude extract confirmed the presence
of diethyl iminomalonate but its purification using col-
umn chromatography failed. However, we noted that this
intermediate did not undergo any thermal cyclization and,
after one hour of heating to 50 °C, gave a mixture of un-
defined decomposition products. Intermolecular cycliza-
tion of a-imino esters seems to begin with nucleophilic
attack of the NH group on a carbon atom at the C=NH
double bond and reaction rate depends on the basicity of
the nitrogen atom. The presence of electron-withdrawing
substituents at a-C reduces the basicity of the imino group
and strongly inhibits nucleophilic addition of the NH
group onto the C=NH double bond. The low basicity of a-
imino esters derived from diethyl a-bromomalonate, ethyl
a-bromonitroacetate and ethyl -bromocyanoacetate
makes the formation of imidazolin-5-one system impossi-
ble.
(3) Goldberg, M. W.; Lehr, H. H. US Patent, US2602086, 1952.
(4) Karjalainen, A. J.; Kurkela, K.; Oiva, A. P. S.; Sulevi, L.
Eur. Patent EP0058047, 1982.
(5) Kumar, P.; Nath, C.; Shanker, K. Pharmazie 1985, 40, 267.
(6) (a) Khan, K. M.; Mughal, U. R.; Samreen, N. A. J. Enzyme
Inhib. Med. Ch. 2010, 25, 29. (b) Amir, M.; Kumar, A.; Ali,
I. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.
2009, 48, 1288. (c) Desai, N. C.; Bhavsar, A. M.; Baldaniya,
B. B. Indian J. Pharm. Sci. 2009, 71, 90.
(7) Zhou, P.; Malamas, M.; Robichaud, A. J. ARKIVOC 2010,
(vi), 84.
(8) Jain, V.; Bhattacharjya, G.; Tej, A.; Suman, C. K.; Gurunath,
R.; Mazhari, B.; Iyer, S. S. K. Proceedings of ASID ’06;
IITK & SID: New Delhi, 2006, 8-12 Oct, 244.
(9) Bahadur, L.; Roy, L. J. Appl. Electrochem. 1999, 29, 109.
(10) (a) Mukerjee, A. K.; Kumar, P. Can. J. Chem. 1982, 60,
317. (b) Kelarev, V. I.; Silin, M. A.; Borisova, O. A. Chem.
Heterocycl. Compd. 2003, 39, 729. (c) Hamidian, H.;
Tikdari, A. M.; Khabazzadeh, H. Molecules 2006, 11, 377.
(d) Wadekar, M. P.; Raut, A. R.; Murhekar, G. H. Der
Pharma Chemica 2010, 2(1), 76.
(11) (a) Kawasaki, A.; Maekawa, K.; Kubo, K.; Igarashi, T.;
Sakurai, T. Tetrahedron 2004, 60, 9517. (b) Topuzyan, V.
O.; Arutyunyan, L. G.; Oganesyan, A. A.; Panosyan, G. A.
Russ. J. Org. Chem. 2007, 43, 936. (c) Topuzyan, V. O.;
Arutyunyan, L. G.; Oganesyan, A. A.; Panosyan, G. A. Russ.
J. Org. Chem. 2008, 44, 474.
(12) 1H NMR (600 MHz, DMSO-d6): d = 11.25 (s, 1 H, NH), 8.38
(d, 2 H, JHH = 7.8 Hz, CHAr), 7.62 (m, 2 H, CHAr), 7.54 (t, 2
H, JHH = 7.8 Hz, CHAr), 7.44 (t, 2 H, JHH = 7.8 Hz, CHAr),
7.40 (t, 2 H, JHH = 7.2 Hz, CHAr), 4.17 (q, 2 H, JHH = 7.2 Hz,
CH3CH2O), 1.14 (t, 3 H, JHH = 7.2 Hz, CH3CH2O). 13C NMR
(150 MHz, DMSO-d6): d = 167.7, 164.8, 162.9, 137.3,
132.3, 129.6, 128.8, 128.7, 128.4, 128.3, 126.5, 86.5, 62.5,
13.8. All 2D NMR experiments for 3a were carried out using
DMSO-d6 as a solvent. COSY correlation list: d [ppm]–d
[ppm](assignment): 1.14–4.17 (CH3CH2O), 4.17–1.14
(CH3CH2O), 7.40–7.44 (p-CH), 7.44–7.40, 7.62 (m-CH),
7.54–7.62, 8.38 (m-CH), 7.62–7.54 (p-CH), 7.62–7.44 (o-
CH), 8.38–7.54 (o-CH). HSQC: correlation list: 13C shift
[ppm]–1H shift [ppm](assignment): 13.7–1.14 (CH3CH2O),
62.5–4.17 (CH3CH2O), 126.5–7.62 (o-CH), 128.3–8.38 (o-
CH), 128.4–7.44 (m-CH), 128.7–7.54 (m-CH), 128.8–7.40
(p-CH), 132.3–7.62 (p-CH). HMBC: correlation list: 1H shift
[ppm]–13C shifts [ppm] (atom connectivity): 1.14–62.5
(ester group CH3CH2O), 4.17–13.7 and 167.7 (ester group
CH3CH2OCO), 7.40–126.5 (p-CH and C-2, phenyl group
A), 7.44–126.5, 128.8 and 137.4 (m-CH and C-2, C-4, C-1,
phenyl group A), 7.54–128.3, 129.6 (m-CH and C-2, C-1,
phenyl group B), 7.62–86.9, 126.5 and 128.8 (o-CH and
quaternary C-2 of the imidazolidine ring, C-2, C-4, phenyl
group A), 7.62–128.3 (p-CH and C-2, phenyl group B),
8.38–128.7, 132.3 and 162.9 (o-CH and C-3, C-4 in phenyl
group B and C=N in the imidazolidine ring), 11.25–86.9,
162.9 and 164.8 (NH group and quaternary C-2, C=N and
C=O in the imidazolidine ring). According to HMBC data,
In summary, our method can be adapted for convenient
synthesis of 5-oxo-2,4-diaryl- and 5-oxo-2,4-diheteroaryl-
2,5-dihydro-1H-imidazol-2-carboxylates from readily
available a-bromo(aryl)- and a-bromo(heteroaryl)ace-
tates in a very simple manner. The optimized procedure
gives the substituted imidazolin-5-ones in moderate to
very good yields.
Supporting Information for this article is available online at
Synlett 2011, No. 3, 315–318 © Thieme Stuttgart · New York